Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?

MLA

Towart, Rob, et al. “Blockade of the I(Ks) Potassium Channel: An Overlooked Cardiovascular Liability in Drug Safety Screening?” Journal of Pharmacological and Toxicological Methods, vol. 60, no. 1, July 2009, pp. 1–10. EBSCOhost, https://doi.org/10.1016/j.vascn.2009.04.197.

APA

Towart, R., Linders, J. T. M., Hermans, A. N., Rohrbacher, J., van der Linde, H. J., Ercken, M., Cik, M., Roevens, P., Teisman, A., & Gallacher, D. J. (2009). Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening? Journal of Pharmacological and Toxicological Methods, 60(1), 1–10. https://doi.org/10.1016/j.vascn.2009.04.197

Chicago

Towart, Rob, Joannes T M Linders, An N Hermans, Jutta Rohrbacher, Henk J van der Linde, Martine Ercken, Miroslav Cik, Peter Roevens, Ard Teisman, and David J Gallacher. 2009. “Blockade of the I(Ks) Potassium Channel: An Overlooked Cardiovascular Liability in Drug Safety Screening?” Journal of Pharmacological and Toxicological Methods 60 (1): 1–10. doi:10.1016/j.vascn.2009.04.197.